Signals mentioning PharmEasy
- AllHome raises ₹200 Cr Series B at $210 Mn valuation to scale interiors house-of-brands
- AllHome raises Rs 200 Cr Series B at Rs 2,000 Cr valuation, led by Bessemer
- AllHome raises Rs 200 Cr Series B at Rs 2,000 Cr valuation, led by Bessemer
- Nilekani-backed Fundamentum targets Rs 1,800-2,500 cr Fund III for growth-stage consumer bets
- Chemists strike against e-pharmacies as 2018 rules lapse, leaving PharmEasy in regulatory limbo
- PharmEasy parent API Holdings pulls IPO, pivots to rights issue for growth funding
- PharmEasy parent API Holdings pulls Rs 6,250 cr IPO, weighs rights issue from Prosus, TPG, Temasek
- PharmEasy parent API Holdings withdraws Rs 6,250 cr DRHP, eyes rights issue
- AIOCD chemists strike nationwide, demand rollback of e-pharmacy rules threatening Tata 1mg, PharmEasy
- Chemists strike nationwide, urge PM to curb online pharmacy and quick commerce drug sales
- 15 lakh chemists down shutters as AIOCD strikes against e-pharmacy discounting
- Orange Health Labs hits ₹180 cr ARR betting diagnostics is the next quick-commerce category
- Orange Health Labs hits ₹180 cr ARR pitching 60-min collection, 6-hr reports against Dr Lal, Metropolis
- 12.4 lakh chemists to shut shop May 20 in nationwide strike against e-pharmacy push
- 12 lakh chemists plan May 20 shutdown protesting e-pharmacy discounts